Ascension must sell 7 ASCs to complete $3.9B AmSurg deal: FTC
Ascension→AmSurg
Jun 2, 2026
Hims & Hers has completed the acquisition of Eucalyptus, a healthcare services other business in the U.S., for an undisclosed amount. Hims Hers acquisitions expand consumer health services with Eucalyptus’s digital care capabilities and local clinical expertise across major markets. The Eucalyptus acquisition supports Hims Hers platform acquisition strategy by strengthening a closed-loop, AI-powered data ecosystem for proactive, personalized healthcare. As a public company acquisition, the healthcare M&A deal is structured as a platform acquisition to scale trust and long-term customer relationships in the U.S., U.K., Australia, and Canada, with growing presence in France, Germany, Ireland, Japan, and Spain.
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Ascension→AmSurg
Jun 2, 2026
WVU Medicine→Independence Health System
Jun 2, 2026
Servier→Edgewise Therapeutics neuromuscular business
Jun 2, 2026
Ascension→AmSurg
Jun 2, 2026
Hims & Hers Health→Eucalyptus
Jun 2, 2026